In summary, we describe the synthesis and testing of short sequence amylin based peptides that demonstrate selective and full antagonist activity at the amylin receptor, are capable of attenuating the deleterious effects of Aβ on neurons and improve spatial memory and features of pathology in transgenic AD mice. Here, IAPP is linked to Alzheimer disease.